跳至主要内容
临床试验/NL-OMON52633
NL-OMON52633招募中不适用

In vivo efficacy of Salbutamol Sandoz versus salbutamol Ventolin GSK in children with asthma - Salsa Study

Canisius Wilhelmina Ziekenhuis0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 15(—)

入选标准

  • , - Informed consent of the parents of children up to 12 yrs
  • of age, and informed consent from parents/caretakers of children and of the,
  • children aged 12-14 years., - Children known with doctor's diagnosed asthma,
  • and a history, or physical examanation, or documented positive response on,
  • bronchodilators following lung function testing, indicating reversibility of
  • airways obstruction, - C-ACT (children astma controle test questionnaire 4-11
  • yrs) or ACT(12-16 yrs) <20 and/or FEV1 decline of at least 15% compared to,
  • personal's best and/or FEV1 < 80 % of predicted value and/or such symptoms
  • that the parents or the physician would administer a bronchodilator

排除标准

  • - Severe Asthmatic attack for which high doses of Salbutamol are needed, -
  • Inability to conduct a lung function test reliably, - Inability to read or
  • understand the Dutch Language, - Concomitant other chronic physical or mental
  • condition that precludes conducting a reliable lung function test.

研究者

发起方
Canisius Wilhelmina Ziekenhuis

相似试验